NanoViricides

NanoViricides is an American nano-biopharmaceutical company that discovers, develops, and commercializes drugs for the treatment of viral infections. It was founded in 2005 and is based in Shelton, Connecticut.
NanoViricides stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

NanoViricides balance sheet

Report period2017 2018 2019 2020 2021 Q2 22
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

NanoViricides cash flows

Report period2017 2018 2019 2020 2021 Q2 22 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

NanoViricides multipliers

Report period2017 2018 2019 2020 2021 Q2 22 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

NanoViricides profitability

Report period2017 2018 2019 2020 2021 Q2 22 TTM
ROA
ROE
ROS
NanoViricides assets
NanoViricides cash flows

NanoViricides dividend policy

The company doesn't provide dividends

NanoViricides shares

TickerNameTypeNominal valueISINPrice
NNVC:USNanoViricidesCommon share-US6300873022$1.49
General information
Company nameNanoViricides
Tags#biotechnology, #vaccines
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address1 Controls Drive Shelton, CT 06484 United States
Mailing address1 Controls Drive Shelton, CT 06484 United States
Websitewww.nanoviricides.com
Information disclosurewww.sec.gov